626201-07-8

Basic information

• Product Name: (R)-3-(3,4-Dihydroxy-phenyl)-2-[(E)-3-(4-hydroxy-3-methoxy-phenyl)-allylamino]-propionic acid methyl ester
• Synonyms: (R)-3-(3,4-Dihydroxy-phenyl)-2-[(E)-3-(4-hydroxy-3-methoxy-phenyl)-allylamino]-propionic acid methyl ester
• CAS NO: 626201-07-8
• Molecular Weight: 373.406
• Mol File: 626201-07-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (R)-3-(3,4-Dihydroxy-phenyl)-2-[(E)-3-(4-hydroxy-3-methoxy-phenyl)-allylamino]-propionic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-3-(3,4-Dihydroxy-phenyl)-2-[(E)-3-(4-hydroxy-3-methoxy-phenyl)-allylamino]-propionic acid methyl ester(626201-07-8)
• EPA Substance Registry System: (R)-3-(3,4-Dihydroxy-phenyl)-2-[(E)-3-(4-hydroxy-3-methoxy-phenyl)-allylamino]-propionic acid methyl ester(626201-07-8)

Safety Data

• Hazardous Substances Data: 626201-07-8(Hazardous Substances Data)

Upstream product

• 20649-42-7 coniferaldehyde 
• 71855-43-1 (R)-(3,4-dihydroxyphenyl)alanine methyl ester 
• 458-36-6 trans-coniferyl aldehyde 
• 618460-38-1 D-clovamide methyl ester 

Relevant articles and documents

Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition

The present invention relates to derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition, more particularly the compounds of the present invention specifically inhibit the activation of T lymphocyte by src homology region 2(SH2) domain of T lymphocyte (lck), so that they can be used for the treatment, prevention and/or diagnosis of graft rejection, autoimmune diseases, inflammatory diseases, etc.